What is known about the passage of fluticasone furoate and vilanterol trifenatate into human breast milk?

Information on excretion of fluticasone furoate or vilanterol trifenatate and/or their metabolites into human milk is insufficient, although other corticosteroids and beta2-agonists are detected in human milk, so a risk to breastfed newborns or infants cannot be excluded.